For the Inventor, By the Inventor

Enter assignee name

Techfields Pharma Co., Ltd.

USPTO Granted Patents = 17

% Expired Patents = 35.3

EPO Patents = 1

Forward Citations = 21

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

Chongxi Yu (17 out of 22 patents)

Lina Xu (13 out of 16 patents)

Yuhua Chen (2 out of 38 patents)

4. Binbing Yan (2 out of 3 patents)

5. Shiqian Tu (2 out of 3 patents)

6. Chongxi Yu (0 patent)

17 patents: Sort by Forward Citations

1. 11857545 - High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions (2024-01-02),

2. 11685739 - High penetration drugs and their compositions thereof for treatment of Parkinson diseases (2023-06-27),

3. 11555014 - High penetration prodrug compositions of prostaglandins and related compounds (2023-01-17),

4. 11541029 - High penetration compositions and their applications (2023-01-03),

5. 11485744 - High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds (2022-11-01),

6. 11479527 - High penetration prodrug compositions of mustards and mustard-related compounds (2022-10-25),

7. 11135153 - High penetration composition and uses thereof (2021-10-05),

8. 11084813 - High penetration drugs and their compositions thereof for treatment of Parkinson diseases (2021-08-10),

9. 10233198 - Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses (2019-03-19),

10. 10233197 - High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds (2019-03-19),

11. 10189774 - High penetration prodrug compositions of mustards and mustard-related compounds (2019-01-29),

12. 9969751 - High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds (2018-05-15),

13. 9872846 - High penetration compositions and uses thereof (2018-01-23),

14. 9718766 - High penetration drugs and their compositions thereof for treatment of parkinson diseases (2017-08-01),

15. 9567329 - High penetration prodrug compositions of 1H-imidazo[4,5-c]quinolin-4-amines and 1H-imidazo[4,5-c]quinolin-4-amine-related compounds and uses thereof (2017-02-14),

Company Overview

Techfields Pharma Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in the research, development, and manufacturing of innovative healthcare solutions. The company focuses on a diverse range of therapeutic areas, including but not limited to oncology, cardiology, and infectious diseases. With its headquarters in Jiangsu, China, Techfields Pharma is committed to advancing medical science through cutting-edge technology and rigorous research methodologies, aiming to improve patient outcomes globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#39 in Jiangsu

#1,709 in China

#35,948 in the World

Techfields Pharma Co., Ltd.

Forward Citations = 21

5 inventors:

Chongxi Yu (17 out of 22 patents)

Lina Xu (13 out of 16 patents)

Yuhua Chen (2 out of 38 patents)

4. Binbing Yan (2 out of 3 patents)

5. Shiqian Tu (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Techfields Pharma Co., Ltd.. Retrieved from https://idiyas.com/company/techfields-pharma-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…